Feasibility of Breast Cancer Risk Evaluation in Women From the General Population

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02997384

Acronym

RIVIERA

Enrollment

600

Registered

2016-12-20

Start date

2016-12-31

Completion date

2018-06-30

Last updated

2016-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastcancer

Brief summary

This study aims to evaluate the feasibility (acceptability) of a consultation dedicated to informing women about their risk of breast cancer and the screening methods recommended for them according to the recommendations in force during a routine consultation at a general practitioner, a gynecologist or a radiologist.

Interventions

OTHERInformation

information of women about their risk of breast cancer and the screening methods recommended for them

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

40 Years to 74 Years

Healthy volunteers

Yes

Inclusion criteria

* Woman from 40 to 74 years old * Understanding the French language

Exclusion criteria

Women will not be eligible for study if they are in any of the following situations: * Cancer active or in the course of treatment type surgery, chemotherapy, or radiotherapy, whether breast or other organ * Recent diagnosis \<1 year of suspicious or cancerous lesions * Psychiatric pathology not compatible with the study * Poor understanding of the French language

Design outcomes

Primary

Measure	Time frame
Percentage of women who agreed to measure their risk with personalized surveillance and screening recommendations during the consultation	up to 1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026